Russian pharmaceutical manufacturers and global drugmakers operating in the local market have called on the need of ...
US artificial intelligence (AI) company OpenAI has acquired Orchestra Bio, adding a platform for coordinating drug ...
Takeda made Orzeyful (oveporexton) available in Japan and China for narcolepsy type 1, while Insmed launched Brinsupri ...
UK biotechnology Touchlight, which is specializing in cell-free DNA manufacturing, today announces that Karen Fallen is ...
ViiV Healthcare, the HIV company majority owned by GSK, today announced that Deborah Waterhouse will step down as chief ...
US biotech Rapport Therapeutics (Nasdaq: RAPP) plans to begin two Phase III trials of RAP-219 in acute bipolar mania in the ...
Median annual net drug launch prices in the USA reached $257,000 in 2025, remaining 35% above their 2022 level despite a ...
US drugmaker Collegium Pharmaceuticals announced a settlement agreement between the company and Germany’s Grunenthal.
US biotech major Amgen and the UK’s AstraZeneca today announced full results from the Phase III CROSSING trial of Tezspire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results